- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Edwards Lifesciences Corp (EW)
Edwards Lifesciences Corp stock price live, this page displays NYSE EW stock exchange data. View the EW premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Edwards Lifesciences Corp real time stock price chart below.
What Is the Edwards Lifesciences Corp Stock Price Today?
The Edwards Lifesciences Corp stock price today is 74.25.
What Is the Stock Symbol for Edwards Lifesciences Corp?
The stock symbol for Edwards Lifesciences Corp is "EW."
What Stock Exchange Does Edwards Lifesciences Corp Trade On?
Edwards Lifesciences Corp is listed and trades on the NYSE stock exchange.
Is Edwards Lifesciences Corp a Good Stock to Buy?
Determining whether Edwards Lifesciences Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EW quote. (ISIN: US28176E1082)
What Is the Edwards Lifesciences Corp Stock Price Today?
The Edwards Lifesciences Corp stock price today is 74.25.
What Is the Stock Symbol for Edwards Lifesciences Corp?
The stock symbol for Edwards Lifesciences Corp is "EW."
What Stock Exchange Does Edwards Lifesciences Corp Trade On?
Edwards Lifesciences Corp is listed and trades on the NYSE stock exchange.
Is Edwards Lifesciences Corp a Good Stock to Buy?
Determining whether Edwards Lifesciences Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EW quote. (ISIN: US28176E1082)
74.25
+0.27(+0.37%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
74.01
74.74
52 wk Range
58.93
95.25
EW Scorecard
Full Analysis
Management has been aggressively buying back shares
EW is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
74.0174.74
52 wk Range
58.9395.25
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
EW Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
80.87
Upside
+8.91%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Edwards Lifesciences Company Profile
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Edwards Lifesciences Corp SWOT Analysis
TAVR Challenges | Edwards Lifesciences faces headwinds in its core TAVR business, revising growth outlook amid hospital workflow pressures and market competition |
TMTT Growth Surge | Explore Edwards' success in Transcatheter Mitral and Tricuspid Therapies, offsetting TAVR slowdown and showcasing portfolio diversification |
Market Positioning | Delve into Edwards' competitive landscape, analyzing its market leadership and strategies to maintain edge in evolving structural heart therapies |
Future Prospects | Analysts project 10% revenue growth and double-digit EPS growth long-term, with price targets ranging from $70 to $90 per share |
Edwards Lifesciences Corp Earnings Call Summary for Q1/2025
- Edwards Lifesciences Q1 2025 EPS of $0.64 beat $0.60 forecast; revenue grew 8% YoY to $1.41B, exceeding expectations
- TAVR sales rose 5.4% to $1.05B; TMTT sales surged 60% to $115M, driving overall growth
- Company raised 2025 sales guidance to $5.7-$6.1B, maintained full-year EPS guidance of $2.40-$2.50
- Stock rose 2.9% in aftermarket trading; P/E ratio of 29.94x suggests potential undervaluation
- Management highlighted innovation focus and hedging strategies to mitigate FX risks
Last Updated: 24-04-2025, 12:06 pm
Read Full TranscriptCompare EW to Peers and Sector
Metrics to compare | EW | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEWPeersSector | |
|---|---|---|---|---|
P/E Ratio | 30.1x | −8.7x | −0.5x | |
PEG Ratio | 0.15 | 0.15 | 0.00 | |
Price/Book | 4.3x | 3.6x | 2.6x | |
Price / LTM Sales | 7.9x | 2.3x | 3.0x | |
Upside (Analyst Target) | 8.1% | 80.6% | 51.9% | |
Fair Value Upside | Unlock | −24.1% | 8.9% | Unlock |
Analyst Ratings
14 Buy
17 Hold
1 Sell
Ratings:
32 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 80.87
(+8.91% Upside)
Earnings
Latest Release
Apr 23, 2025
EPS / Forecast
0.64 / 0.60
Revenue / Forecast
1.41B / 1.40B
FAQ
What Is the Edwards Lifesciences (EW) Stock Price Today?
The Edwards Lifesciences stock price today is 74.25.
What Stock Exchange Does Edwards Lifesciences Trade On?
Edwards Lifesciences is listed and trades on the New York Stock Exchange stock exchange.
What Is the Stock Symbol for Edwards Lifesciences?
The stock symbol for Edwards Lifesciences is "EW."
What Is the Edwards Lifesciences Market Cap?
As of today, Edwards Lifesciences market cap is 43.68B.
What Is Edwards Lifesciences's Earnings Per Share (TTM)?
The Edwards Lifesciences EPS (TTM) is 2.42.
When Is the Next Edwards Lifesciences Earnings Date?
Edwards Lifesciences will release its next earnings report on 23 Jul 2025.
From a Technical Analysis Perspective, Is EW a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Edwards Lifesciences Stock Split?
Edwards Lifesciences has split 3 times.
How Many Employees Does Edwards Lifesciences Have?
Edwards Lifesciences has 15800 employees.
What is the current trading status of Edwards Lifesciences (EW)?
As of 20 Jun 2025, Edwards Lifesciences (EW) is trading at a price of 74.25, with a previous close of 73.98. The stock has fluctuated within a day range of 74.01 to 74.74, while its 52-week range spans from 58.93 to 95.25.
What Is Edwards Lifesciences (EW) Price Target According to Analysts?
The average 12-month price target for Edwards Lifesciences is USD80.86793, with a high estimate of USD95 and a low estimate of USD61. 14 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +8.91% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.